Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, oral for treating osteoporosis

CCG Approval Status:

Date Added: 24 - Oct - 2019
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of ORAL BISPHOSPHONATES (alendronic acid, ibandronic acid and risedronate sodium) for treating osteoporosis in accordance with NICE TA464.